Table 4 Health service resource use during osimertinib treatment
Sum | Main | DT | Median | Minim | Maxim | |
|---|---|---|---|---|---|---|
Patients | ||||||
HOSPITAL CARE health resources (n = 155) | ||||||
R01: Hospital visits/admissions (number) | 1421 | 9.2 | 14.0 | 1 | 0 | 73 |
R02: Visits to the Medical Oncologist (number) | 2011 | 13.0 | 10.0 | 11 | 0 | 56 |
R03: Visits to other hospital Physician (number) | 478 | 3.1 | 5.5 | 1 | 0 | 48 |
R04: Visits to the Hospital Nurse (number) | 560 | 3.6 | 6.5 | 0 | 0 | 39 |
R05: Emergency room visits (without admission) (n.) | 143 | 0.9 | 1.6 | 0 | 0 | 9 |
R06: Hospitalization in the emergency room (days) | 54 | 0.3 | 1.0 | 0 | 0 | 6 |
R07: Hospitalization in ward (days) | 759 | 4.9 | 14.6 | 0 | 0 | 133 |
IMAGING TESTS (n = 155) | ||||||
R08: Chest x-ray (number) | 333 | 2.1 | 3.1 | 1 | 0 | 16 |
R09: CT scan (number) | 475 | 3.1 | 2.5 | 3 | 0 | 12 |
R10: Magnetic resonance (number) | 113 | 0.7 | 1.3 | 0 | 0 | 6 |
R11: Endobronchial ultrasound (number) | 2 | 0.0 | 0.2 | 0 | 0 | 2 |
R12: Esophageal Endoscopic Ultrasound (number) | 2 | 0.0 | 0.2 | 0 | 0 | 2 |
R13: Other tests (number) | 65 | 0.4 | 1.2 | 0 | 0 | 10 |
OTHER complementary tests (n = 155) | ||||||
R14: Bone scintigraphy (number) | 32 | 0.2 | 0.6 | 0 | 0 | 3 |
R15: Sputum cytology (number) | 1 | 0.0 | 0.1 | 0 | 0 | 1 |
R16: Thoracentesis (number) | 12 | 0.1 | 0.3 | 0 | 0 | 3 |
R17: Biopsy (number) | 64 | 0.4 | 1.5 | 0 | 0 | 9 |
R18: Bronchoscopy (number) | 12 | 0.1 | 0.4 | 0 | 0 | 4 |
R19: Mediastinoscopy (number) | 0 | – | – | – | – | – |
R20: Mediastinotomy (number) | 0 | – | – | – | – | – |
R21: Thoracoscopy (number) | 0 | – | – | – | – | – |
R22: Spirometry (number) | 5 | 0.0 | 0.2 | 0 | 0 | 1 |
R23: Plethysmography (number) | 0 | – | – | – | – | – |
R24: Electrocardiogram (number) | 198 | 1.3 | 3.6 | 0 | 0 | 30 |
R25: Other tests (number) | 18 | 0.1 | 0.4 | 0 | 0 | 4 |
PRIMARY CARE health resources (n = 152) | ||||||
R26: Visits to primary care (number) | 271 | 1.8 | 5.4 | 0 | 0 | 39 |
R27: Visits to primary care Physician (number) | 257 | 1.7 | 5.0 | 0 | 0 | 36 |
R28: Visits to primary care Nurse (number) | 166 | 1.1 | 5.1 | 0 | 0 | 37 |
R29: Tests performed (number) | 112 | 0.7 | 4.8 | 0 | 0 | 50 |
R30: Chest x-ray (number) | 20 | 0.1 | 0.9 | 0 | 0 | 10 |
R31: Complete blood count (number) | 224 | 1.5 | 6.0 | 0 | 0 | 50 |
R32: Other tests (number) | 6 | 0.0 | 0.3 | 0 | 0 | 3 |
LABORATORY TESTS (n = 155) | ||||||
R33: Immunohistochemistry (number) | 35 | 0.2 | 1.3 | 0 | 0 | 15 |
R34: Molecular tests (EGFR, ALK, ROS1, BRAF) (num.) | 66 | 0.4 | 1.0 | 0 | 0 | 5 |
R35: Complete blood count (number) | 1.873 | 12.1 | 10.5 | 9 | 0 | 62 |
R36: Blood chemistry (number) | 1.859 | 12.0 | 10.4 | 9 | 0 | 62 |
R37: Proteins in urine (number) | 310 | 2.0 | 6.3 | 0 | 0 | 35 |
R38: Other tests (number) | 119 | 0.8 | 3.2 | 0 | 0 | 29 |
SURGERIES (n = 155) | ||||||
R39: Pneumectomy (number) | 0 | – | – | – | – | – |
R40: Lobectomy (number) | 0 | – | – | – | – | – |
R41: Segmentation or wedge resection (number) | 0 | – | – | – | – | – |
R42: Sleeve resection (number) | 0 | – | – | – | – | – |
R43: Others (number) | 5 | 0.0 | 0.2 | 0 | 0 | 2 |
OTHER RESOURCES/SUPPORT (n = 155) | ||||||
R44: Radiofrequency ablation (number) | 1 | 0.0 | 0.1 | 0 | 0 | 1 |
R45: Radiotherapy palliative (number of sessions) | 159 | 1.0 | 4.0 | 0 | 0 | 40 |
R46: Pleurodesis (number) | 1 | 0.0 | 0.1 | 0 | 0 | 1 |
R47: Corticosteroids | no | 117 | 75.5% | yes | 38 | 24.5% |
R48: Bisphosphonates | no | 142 | 91.6% | yes | 13 | 8.4% |
R49: Stimulants of erythropoietin | no | 151 | 97.4% | yes | 4 | 2.6% |
R50: Blood transfusions | no | 147 | 94.8% | yes | 8 | 5.2% |
R51: Enteral nutrition | no | 153 | 98.7% | yes | 2 | 1.3% |
R52: Others | no | 145 | 93.5% | yes | 10 | 6.5% |